Cellectis S.A.

IPO

Cellectis S.A. is a biotech company in Paris, France, founded in 1999. It has raised $300.0M across 3 rounds, most recently a $140.0M Corporate Round in May 2024.

Home | Cellectis

Headquarters
Paris
Employees
201–500
Founded
1999
Business Model
B2B
Total Funding
$300.0M
Last Round
$140.0M Corporate RoundMay 2024
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Founded in 1999, Cellectis is a clinical-stage biopharmaceutical company with 25 years of expertise in gene editing using its proprietary TALEN technology and PulseAgile electroporation system. The company pioneers allogeneic off-the-shelf CAR T-cell therapies (UCART) targeting cancers including B-ALL and non-Hodgkin lymphoma. Cellectis is listed on Nasdaq (CLLS) and Euronext Growth, with operations in Paris, New York, and Raleigh.

Summary

It lists 201–500 employees. It has raised $300.0M in total across 3 rounds, most recently a $140.0M Corporate Round in May 2024. Investors include AstraZeneca and Pfizer Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundMay 2024
$140.0M

Sign up to see all 4 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellectis S.A. on Indexed.vc
<a href="https://indexed.vc/companies/cellectis-s-a"><img src="https://indexed.vc/api/badge/company/cellectis-s-a" alt="Cellectis S.A. on Indexed.vc" width="260" height="76" /></a>